UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism

Nature communications, 2023-09, Vol.14 (1), p.5938-5938, Article 5938

2023

Link zum Volltext

Verfügbarkeit prüfen

Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism

Journal of computer-aided molecular design, 2010-03, Vol.24 (3), p.237-256

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Pharmacological Properties of a Potent and Selective Novel Nonsteroidal Progesterone Receptor Agonist Tanaproget

The Journal of biological chemistry, 2005-08, Vol.280 (31), p.28468-28475

2005

Link zum Volltext

Verfügbarkeit prüfen

Understanding the Selectivity of Genistein for Human Estrogen Receptor-β Using X-Ray Crystallography and Computational Methods

Structure (London), 2004-12, Vol.12 (12), p.2197-2207

2004

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of Estrogen Receptor-β Selective Ligands

Journal of the American Chemical Society, 2004-11, Vol.126 (46), p.15106-15119

2004

Link zum Volltext

Verfügbarkeit prüfen

ERβ ligands. Part 6 6H -Chromeno [4,3 -b]quinolines as a new series of estrogen receptor β-selective ligands

Bioorganic & medicinal chemistry letters, 2007-07, Vol.17 (14), p.4053-4056

2007

Link zum Volltext

Verfügbarkeit prüfen

Identification of Phenylsulfone-Substituted Quinoxaline (WYE-672) as a Tissue Selective Liver X-receptor (LXR) Agonist

Journal of medicinal chemistry, 2010-04, Vol.53 (8), p.3296-3304

2010

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates

Journal of medicinal chemistry, 2010-02, Vol.53 (4), p.1774-1787

2010

Link zum Volltext

Verfügbarkeit prüfen

Critical evaluation of methods to incorporate entropy loss upon binding in high-throughput docking

Proteins, structure, function, and bioinformatics, 2007-02, Vol.66 (2), p.422-435

2007

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones

Bioorganic & medicinal chemistry letters, 2005-06, Vol.15 (12), p.3137-3142

2005

Link zum Volltext

Verfügbarkeit prüfen

7-Substituted 2-phenyl-benzofurans as ERβ selective ligands

Bioorganic & medicinal chemistry letters, 2004-10, Vol.14 (19), p.4925-4929

2004

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor β ligands: Design and synthesis of new 2-phenyl-isoindole-1,3-diones

Bioorganic & medicinal chemistry letters, 2007, Vol.17 (1), p.118-122

2007

Link zum Volltext

Verfügbarkeit prüfen

Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

Journal of medicinal chemistry, 1997-08, Vol.40 (17), p.2706-2725

1997

Link zum Volltext

Verfügbarkeit prüfen

Molecular determinants of ERα and ERβ involved in selectivity of 16α-iodo-17β estradiol

The Journal of steroid biochemistry and molecular biology, 2004, Vol.88 (1), p.17-26

2004

Link zum Volltext

Verfügbarkeit prüfen

3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists

Journal of medicinal chemistry, 1996-07, Vol.39 (15), p.3030-3034

1996

Link zum Volltext

Verfügbarkeit prüfen

Structure and torsional potential function of allylsilane: results from MM2 and ab initio calculations [3-21G()]

Journal of organic chemistry, 1986-05, Vol.51 (10), p.1884-1885

1986

Link zum Volltext

Verfügbarkeit prüfen

ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands

Bioorganic & medicinal chemistry letters, 2007-07, Vol.17 (14), p.4053-4056

2007

Link zum Volltext

Verfügbarkeit prüfen

Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines

Bioorganic & medicinal chemistry letters, 1995-09, Vol.5 (17), p.1977-1982

1995

Link zum Volltext

Verfügbarkeit prüfen

Relative Energies and Structural Features of Small Amines and Their Ammonium Analogs: Results From 6-31G Optimizations and an Mm2 Ammonium Force Field

The international journal of supercomputer applications and high performance computing, 1994-03, Vol.8 (1), p.35-46

1994

Link zum Volltext

Verfügbarkeit prüfen

ERβ ligands. Part 6: 6 H-Chromeno[4,3- b]quinolines as a new series of estrogen receptor β-selective ligands

Bioorganic & medicinal chemistry letters, 2007, Vol.17 (14), p.4053-4056

2007

Link zum Volltext

Verfügbarkeit prüfen

A force field (MM2) study of 1,2-di-tert-butyl- and 1,2-disilylcyclohexanes

Journal of organic chemistry, 1988-11, Vol.53 (24), p.5658-5663

1988

Link zum Volltext

Verfügbarkeit prüfen

Preparation of (.alpha.,.alpha.-dichlorobenzyl)silanes and (.alpha.-halobenzyl)silanes

Organometallics, 1992-02, Vol.11 (2), p.859-863

1992

Link zum Volltext

Verfügbarkeit prüfen

Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol

The Journal of steroid biochemistry and molecular biology, 2004-01, Vol.88 (1), p.17

2004

Link zum Volltext

Verfügbarkeit prüfen

6-Azasteroids : potent dual inhibitors of human type 1 and 2 steroid 5α-reductase

Journal of medicinal chemistry, 1993-12, Vol.36 (26), p.4313-4315

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism

Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism

Molecular and Pharmacological Properties of a Potent and Selective Novel Nonsteroidal Progesterone Receptor Agonist Tanaproget

Understanding the Selectivity of Genistein for Human Estrogen Receptor-β Using X-Ray Crystallography and Computational Methods

Structure-Based Design of Estrogen Receptor-β Selective Ligands

ERβ ligands. Part 6 6H -Chromeno [4,3 -b]quinolines as a new series of estrogen receptor β-selective ligands

Identification of Phenylsulfone-Substituted Quinoxaline (WYE-672) as a Tissue Selective Liver X-receptor (LXR) Agonist

Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates

Critical evaluation of methods to incorporate entropy loss upon binding in high-throughput docking

Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones

7-Substituted 2-phenyl-benzofurans as ERβ selective ligands

Estrogen receptor β ligands: Design and synthesis of new 2-phenyl-isoindole-1,3-diones

Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

Molecular determinants of ERα and ERβ involved in selectivity of 16α-iodo-17β estradiol

3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists

Structure and torsional potential function of allylsilane: results from MM2 and ab initio calculations [3-21G()]

ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands

Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines

Relative Energies and Structural Features of Small Amines and Their Ammonium Analogs: Results From 6-31G Optimizations and an Mm2 Ammonium Force Field

ERβ ligands. Part 6: 6 H-Chromeno[4,3- b]quinolines as a new series of estrogen receptor β-selective ligands

A force field (MM2) study of 1,2-di-tert-butyl- and 1,2-disilylcyclohexanes

Structure-Activity Relationships for Inhibition of Type 1 and 2 Human 5.alpha.-Reductase and Human Adrenal 3.beta.-Hydroxy-.DELTA.5-steroid Dehydrogenase/3-Keto-.DELTA.5-steroid Isomerase by 6-Azaandrost-4-en-3-ones: Optimization of the C17 Substituent

Preparation of (.alpha.,.alpha.-dichlorobenzyl)silanes and (.alpha.-halobenzyl)silanes

Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol

6-Azasteroids : potent dual inhibitors of human type 1 and 2 steroid 5α-reductase

Suchergebnisse filtern